Cargando…
Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected feature...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154627/ https://www.ncbi.nlm.nih.gov/pubmed/31412144 http://dx.doi.org/10.1002/rcm.8551 |
_version_ | 1783521858064220160 |
---|---|
author | Nagai, Koshi Uranbileg, Baasanjav Chen, Zhen Fujioka, Amane Yamazaki, Takahiro Matsumoto, Yotaro Tsukamoto, Hiroki Ikeda, Hitoshi Yatomi, Yutaka Chiba, Hitoshi Hui, Shu‐Ping Nakazawa, Toru Saito, Ritsumi Koshiba, Seizo Aoki, Junken Saigusa, Daisuke Tomioka, Yoshihisa |
author_facet | Nagai, Koshi Uranbileg, Baasanjav Chen, Zhen Fujioka, Amane Yamazaki, Takahiro Matsumoto, Yotaro Tsukamoto, Hiroki Ikeda, Hitoshi Yatomi, Yutaka Chiba, Hitoshi Hui, Shu‐Ping Nakazawa, Toru Saito, Ritsumi Koshiba, Seizo Aoki, Junken Saigusa, Daisuke Tomioka, Yoshihisa |
author_sort | Nagai, Koshi |
collection | PubMed |
description | RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected features, reproducibility of methods, and identification of metabolites. In addition, information on localization of metabolites in tumor tissue is needed for functional analysis. Here, we developed a wide‐polarity global metabolomics (G‐Met) method, identified HCC biomarkers in human liver samples by high‐definition mass spectrometry (HDMS), and demonstrated localization in cryosections using desorption electrospray ionization MS imaging (DESI‐MSI) analysis. METHODS: Metabolic profiling of tumor (n = 38) and nontumor (n = 72) regions in human livers of HCC was performed by an ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight MS (UHPLC/QTOFMS) instrument equipped with a mixed‐mode column. The HCC biomarker candidates were extracted by multivariate analyses and identified by matching values of the collision cross section and their fragment ions on the mass spectra obtained by HDMS. Cryosections of HCC livers, which included both tumor and nontumor regions, were analyzed by DESI‐MSI. RESULTS: From the multivariate analysis, m/z 904.83 and m/z 874.79 were significantly high and low, respectively, in tumor samples and were identified as triglyceride (TG) 16:0/18:1(9Z)/20:1(11Z) and TG 16:0/18:1(9Z)/18:2(9Z,12Z) using the synthetic compounds. The TGs were clearly localized in the tumor or nontumor areas of the cryosection. CONCLUSIONS: Novel biomarkers for HCC were identified by a comprehensive and reproducible G‐Met method with HDMS using a mixed‐mode column. The combination analysis of UHPLC/QTOFMS and DESI‐MSI revealed that the different molecular species of TGs were associated with tumor distribution and were useful for characterizing the progression of tumor cells and discovering prospective biomarkers. |
format | Online Article Text |
id | pubmed-7154627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71546272020-04-14 Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging Nagai, Koshi Uranbileg, Baasanjav Chen, Zhen Fujioka, Amane Yamazaki, Takahiro Matsumoto, Yotaro Tsukamoto, Hiroki Ikeda, Hitoshi Yatomi, Yutaka Chiba, Hitoshi Hui, Shu‐Ping Nakazawa, Toru Saito, Ritsumi Koshiba, Seizo Aoki, Junken Saigusa, Daisuke Tomioka, Yoshihisa Rapid Commun Mass Spectrom Mass Spectrometry for Clinical Diagnosis RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected features, reproducibility of methods, and identification of metabolites. In addition, information on localization of metabolites in tumor tissue is needed for functional analysis. Here, we developed a wide‐polarity global metabolomics (G‐Met) method, identified HCC biomarkers in human liver samples by high‐definition mass spectrometry (HDMS), and demonstrated localization in cryosections using desorption electrospray ionization MS imaging (DESI‐MSI) analysis. METHODS: Metabolic profiling of tumor (n = 38) and nontumor (n = 72) regions in human livers of HCC was performed by an ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight MS (UHPLC/QTOFMS) instrument equipped with a mixed‐mode column. The HCC biomarker candidates were extracted by multivariate analyses and identified by matching values of the collision cross section and their fragment ions on the mass spectra obtained by HDMS. Cryosections of HCC livers, which included both tumor and nontumor regions, were analyzed by DESI‐MSI. RESULTS: From the multivariate analysis, m/z 904.83 and m/z 874.79 were significantly high and low, respectively, in tumor samples and were identified as triglyceride (TG) 16:0/18:1(9Z)/20:1(11Z) and TG 16:0/18:1(9Z)/18:2(9Z,12Z) using the synthetic compounds. The TGs were clearly localized in the tumor or nontumor areas of the cryosection. CONCLUSIONS: Novel biomarkers for HCC were identified by a comprehensive and reproducible G‐Met method with HDMS using a mixed‐mode column. The combination analysis of UHPLC/QTOFMS and DESI‐MSI revealed that the different molecular species of TGs were associated with tumor distribution and were useful for characterizing the progression of tumor cells and discovering prospective biomarkers. John Wiley and Sons Inc. 2019-11-06 2020-04 /pmc/articles/PMC7154627/ /pubmed/31412144 http://dx.doi.org/10.1002/rcm.8551 Text en © 2019 The Authors. Rapid Communications in Mass Spectrometry published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Mass Spectrometry for Clinical Diagnosis Nagai, Koshi Uranbileg, Baasanjav Chen, Zhen Fujioka, Amane Yamazaki, Takahiro Matsumoto, Yotaro Tsukamoto, Hiroki Ikeda, Hitoshi Yatomi, Yutaka Chiba, Hitoshi Hui, Shu‐Ping Nakazawa, Toru Saito, Ritsumi Koshiba, Seizo Aoki, Junken Saigusa, Daisuke Tomioka, Yoshihisa Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
title | Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
title_full | Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
title_fullStr | Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
title_full_unstemmed | Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
title_short | Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
title_sort | identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging |
topic | Mass Spectrometry for Clinical Diagnosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154627/ https://www.ncbi.nlm.nih.gov/pubmed/31412144 http://dx.doi.org/10.1002/rcm.8551 |
work_keys_str_mv | AT nagaikoshi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT uranbilegbaasanjav identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT chenzhen identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT fujiokaamane identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT yamazakitakahiro identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT matsumotoyotaro identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT tsukamotohiroki identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT ikedahitoshi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT yatomiyutaka identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT chibahitoshi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT huishuping identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT nakazawatoru identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT saitoritsumi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT koshibaseizo identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT aokijunken identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT saigusadaisuke identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging AT tomiokayoshihisa identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging |